Key Shareholders
| Key Shareholders | Number (mio. shares) |
% | |
|---|---|---|---|
| Biotechnology Value Fund (BVF) Inc. | 18.8 | 19.0% | |
| dievini Hopp BioTech holding GmbH & Co KG | 16.3 | 16.5% | |
| Varuma AG | 12.0 | 12.1% | |
| Affiris AG | 11.0 | 11.1% |
Affiris shares are held by: Santo Venture Capital GmbH |
| Eli Lilly and Company | 3.6 | 3.7% | |
| AC Immune Management and Board of Directors | 3.1 | 3.1% | |
| BlackRock Financial Management, Inc. | 1.9 | 1.9% | |
| Redmile | 1.8 | 1.8% |